ACS Medicinal Chemistry Letters
Letter
(12) Huang, Z.; Roy, P.; Waxman, D. J. Role of human liver
microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation
of cyclophosphamide and ifosfamide. Biochem. Pharmacol. 2000, 59,
961−972.
(29) Molnar, F.; Kublbeck, J.; Jyrkkarinne, J.; Prantner, V.;
Honkakoski, P. An update on the constitutive androstane receptor
(CAR). Drug Metabol. Drug Interact. 2013, 28, 79−93.
(30) Lynch, C.; Pan, Y.; Li, L.; Ferguson, S. S.; Xia, M.; Swaan, P.
W.; Wang, H. Identification of novel activators of constitutive
androstane receptor from FDA-approved drugs by integrated
computational and biological approaches. Pharm. Res. 2013, 30,
489−501.
(31) Lynch, C.; Zhao, J.; Huang, R.; Xiao, J.; Li, L.; Heyward, S.;
Xia, M.; Wang, H. Quantitative high-throughput identification of
drugs as modulators of human constitutive androstane receptor. Sci.
Rep. 2015, 5, 10405.
(32) Lynch, C.; Mackowiak, B.; Huang, R.; Li, L.; Heyward, S.;
Sakamuru, S.; Wang, H.; Xia, M. Identification of modulators that
activate the constitutive androstane receptor from the Tox21 10K
compound library. Toxicol. Sci. 2019, 167, 282−292.
(33) Smutny, T.; Nova, A.; Drechslerova, M.; Carazo, A.; Hyrsova,
L.; Hruskova, Z. R.; Kunes, J.; Pour, M.; Spulak, M.; Pavek, P. 2-(3-
Methoxyphenyl)quinazoline derivatives: a new class of direct
constitutive androstane receptor (CAR) agonists. J. Med. Chem.
2016, 59, 4601−4610.
(34) Tschuor, C.; Kachaylo, E.; Limani, P.; Raptis, D. A.; Linecker,
M.; Tian, Y.; Herrmann, U.; Grabliauskaite, K.; Weber, A.;
Columbano, A.; Graf, R.; Humar, B.; Clavien, P. A. Constitutive
androstane receptor (Car)-driven regeneration protects liver from
failure following tissue loss. J. Hepatol. 2016, 65, 66−74.
(35) Shizu, R.; Min, J.; Sobhany, M.; Pedersen, L. C.; Mutoh, S.;
Negishi, M. Interaction of the phosphorylated DNA-binding domain
in nuclear receptor CAR with its ligand-binding domain regulates
CAR activation. J. Biol. Chem. 2018, 293, 333−344.
(36) Shizu, R.; Osabe, M.; Perera, L.; Moore, R.; Sueyoshi, T.;
Negishi, M. Phosphorylated nuclear receptor CAR forms a
homodimer to repress its constitutive activity for ligand activation.
Mol. Cell. Biol. 2017, 37, No. e00649-16.
(37) Kandel, B. A.; Thomas, M.; Winter, S.; Damm, G.; Seehofer,
D.; Burk, O.; Schwab, M.; Zanger, U. M. Genomewide comparison of
the inducible transcriptomes of nuclear receptors CAR, PXR and
PPARα in primary human hepatocytes. Biochim. Biophys. Acta, Gene
Regul. Mech. 2016, 1859, 1218−1227.
(13) Code, E. L.; Crespi, C. L.; Penman, B. W.; Gonzalez, F. J.;
Chang, T. K.; Waxman, D. J. Human cytochrome P4502B6:
interindividual hepatic expression, substrate specificity, and role in
procarcinogen activation. Drug Metab. Dispos. 1997, 25, 985−993.
(14) Wang, D.; Li, L.; Yang, H.; Ferguson, S. S.; Baer, M. R.;
Gartenhaus, R. B.; Wang, H. The constitutive androstane receptor is a
novel therapeutic target facilitating cyclophosphamide-based treat-
ment of hematopoietic malignancies. Blood 2013, 121, 329−338.
(15) Hedrich, W. D.; Xiao, J.; Heyward, S.; Zhang, Y.; Zhang, J.;
Baer, M. R.; Hassan, H. E.; Wang, H. Activation of the constitutive
androstane receptor increases the therapeutic index of CHOP in
lymphoma treatment. Mol. Cancer Ther. 2016, 15, 392−401.
(16) Kobayashi, K.; Sueyoshi, T.; Inoue, K.; Moore, R.; Negishi, M.
Cytoplasmic accumulation of the nuclear receptor CAR by a
tetratricopeptide repeat protein in HepG2 cells. Mol. Pharmacol.
2003, 64, 1069−1075.
(17) Honkakoski, P.; Negishi, M. Protein serine/threonine
phosphatase inhibitors suppress phenobarbital-induced Cyp2b10
gene transcription in mouse primary hepatocytes. Biochem. J. 1998,
330, 889−895.
(18) Swales, K.; Kakizaki, S.; Yamamoto, Y.; Inoue, K.; Kobayashi,
K.; Negishi, M. Novel CAR-mediated mechanism for synergistic
activation of two distinct elements within the human cytochrome
P450 2B6 gene in HepG2 cells. J. Biol. Chem. 2005, 280, 3458−3466.
(19) Mackowiak, B.; Wang, H. 2016. Mechanisms of xenobiotic
receptor activation: Direct vs. indirect. Biochim. Biophys. Acta, Gene
Regul. Mech. 2016, 1859, 1130−1140.
(20) Xu, R. X.; Lambert, M. H.; Wisely, B. B.; Warren, E. N.;
Weinert, E. E.; Waitt, G. M.; Williams, J. D.; Collins, J. L.; Moore, L.
B.; Willson, T. M.; Moore, J. T. A structural basis for constitutive
activity in the human CAR/RXRalpha heterodimer. Mol. Cell 2004,
16, 919−928.
(21) Xie, W.; Barwick, J. L.; Downes, M.; Blumberg, B.; Simon, C.
M.; Nelson, M. C.; Neuschwander-Tetri, B. A.; Brunt, E. M.;
Guzelian, P. S.; Evans, R. M. Humanized xenobiotic response in mice
expressing nuclear receptor SXR. Nature 2000, 406, 435−439.
(22) Moore, L. B.; Parks, D. J.; Jones, S. A.; Bledsoe, R. K.; Consler,
T. G.; Stimmel, J. B.; Goodwin, B.; Liddle, C.; Blanchard, S. G.;
Willson, T. M.; Collins, J. L.; Kliewer, S. A. Orphan nuclear receptors
constitutive androstane receptor and pregnane X receptor share
xenobiotic and steroid ligands. J. Biol. Chem. 2000, 275, 15122−
15127.
(38) Trott, O.; Olson, A. J. AutoDock Vina: improving the speed
and accuracy of docking with a new scoring function, efficient
optimization and multithreading. J. Comput. Chem. 2009, 31, 455−
461.
(23) Moore, L. B.; Maglich, J. M.; McKee, D. D.; Wisely, B.; Willson,
T. M.; Kliewer, S. A.; Lambert, M. H.; Moore, J. T. Pregnane X
receptor (PXR), constitutive androstane receptor (CAR), and
benzoate X receptor (BXR) define three pharmacologically distinct
classes of nuclear receptors. Mol. Endocrinol. 2002, 16, 977−986.
(24) Willson, T. M.; Kliewer, S. A. PXR, CAR and drug metabolism.
Nat. Rev. Drug Discovery 2002, 1, 259−266.
(25) Cherian, M. T.; Chai, S. C.; Chen, T. Small-molecule
modulators of the constitutive androstane receptor. Expert Opin.
Drug Metab. Toxicol. 2015, 11, 1099−1114.
(26) Faucette, S. R.; Zhang, T. C.; Moore, R.; Sueyoshi, T.;
Omiecinski, C. J.; LeCluyse, E. L.; Negishi, M.; Wang, H. Relative
activation of human pregnane X receptor versus constitutive
androstane receptor defines distinct classes of CYP2B6 and
CYP3A4 inducers. J. Pharmacol. Exp. Ther. 2006, 320, 72−80.
(27) Maglich, J. M.; Stoltz, C. M.; Goodwin, B.; Hawkins-Brown, D.;
Moore, J. T.; Kliewer, S. A. Nuclear pregnane X receptor and
constitutive androstane receptor regulate overlapping but distinct sets
of genes involved in xenobiotic detoxification. Mol. Pharmacol. 2002,
62, 638−646.
(28) Kliewer, S. A.; Goodwin, B.; Willson, T. M. The nuclear
pregnane X receptor: a key regulator of xenobiotic metabolism.
Endocr. Rev. 2002, 23, 687−702.
F
ACS Med. Chem. Lett. XXXX, XXX, XXX−XXX